The Importance of Diversity in MBC Clinical Trials
Clinical trials are done to test the safety of new treatments and how well they work. Doctors need to know how treatments will work in all types of people who will receive them. This knowledge comes when trials enroll diverse groups of people. Diversity in clinical trials is good science and benefits everyone.
Visit the links below to learn more about why diversity in clinical trials is important.
- BreastCancerTrials.org (video): Dr. Sabrina Mayhew explains why diversity in clinical trials is good science that benefits everyone
- CenterWatch: Diversity in clinical trials leads to better outcomes for patients by taking into account how race, sex, age, and other factors can impact response to treatment
- Harvard Medical School: The population enrolled in clinical trials needs to represent the groups of people who will receive the treatment once it is approved